BR9912051A - Uso de composto, e, processo para tratamento e prevenção de discinesia. - Google Patents
Uso de composto, e, processo para tratamento e prevenção de discinesia.Info
- Publication number
- BR9912051A BR9912051A BR9912051-8A BR9912051A BR9912051A BR 9912051 A BR9912051 A BR 9912051A BR 9912051 A BR9912051 A BR 9912051A BR 9912051 A BR9912051 A BR 9912051A
- Authority
- BR
- Brazil
- Prior art keywords
- dyskinesia
- prevention
- treatment
- compost
- dystonia
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9802546A SE9802546D0 (sv) | 1998-07-15 | 1998-07-15 | Medicinal product and method for treatment and prevention of dyskinesia |
PCT/SE1999/001274 WO2000003714A1 (en) | 1998-07-15 | 1999-07-15 | Medicinal product and method for treatment and prevention of dyskinesia |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9912051A true BR9912051A (pt) | 2001-04-03 |
Family
ID=20412091
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9912051-8A BR9912051A (pt) | 1998-07-15 | 1999-07-15 | Uso de composto, e, processo para tratamento e prevenção de discinesia. |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1096935A1 (sv) |
JP (1) | JP2002520361A (sv) |
AU (1) | AU5456899A (sv) |
BR (1) | BR9912051A (sv) |
CA (1) | CA2336998A1 (sv) |
SE (1) | SE9802546D0 (sv) |
WO (1) | WO2000003714A1 (sv) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE46117E1 (en) | 1999-12-22 | 2016-08-23 | Teva Pharmaceuticals International Gmbh | Modulators of dopamine neurotransmission |
GB0002100D0 (en) | 2000-01-28 | 2000-03-22 | Novartis Ag | Organic compounds |
CA2425125A1 (en) * | 2000-10-12 | 2002-07-25 | Kjell A. Svensson | Method of treating parkinson's disease |
AR031152A1 (es) | 2000-10-31 | 2003-09-10 | Upjohn Co | Tratamientos nuevos para el sindrome de piernas inquietas |
US6670378B2 (en) * | 2001-05-08 | 2003-12-30 | Pharmacia & Upjohn Company | Method of treating Parkinson's disease |
DK2618826T3 (en) * | 2010-09-20 | 2016-08-01 | A Carlsson Res Ab | Phenylpiperdine FOR TREATMENT OF DEMENTIA |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DD155065A5 (de) * | 1979-12-05 | 1982-05-12 | Astra Laekemedel Ab | Verfahren zur herstellung von phenylazacycloalkanen |
US4937346A (en) * | 1979-12-05 | 1990-06-26 | Per Arvid Emil Carlsson | Phenyl-azacykloalkanes |
US4719219A (en) * | 1982-03-30 | 1988-01-12 | Per A. E. Carlsson | Phenyl-azacycloalkanes and use thereof in treatment of central nervous system disorders |
-
1998
- 1998-07-15 SE SE9802546A patent/SE9802546D0/sv unknown
-
1999
- 1999-07-15 JP JP2000559849A patent/JP2002520361A/ja active Pending
- 1999-07-15 WO PCT/SE1999/001274 patent/WO2000003714A1/en not_active Application Discontinuation
- 1999-07-15 AU AU54568/99A patent/AU5456899A/en not_active Abandoned
- 1999-07-15 BR BR9912051-8A patent/BR9912051A/pt not_active IP Right Cessation
- 1999-07-15 CA CA002336998A patent/CA2336998A1/en not_active Abandoned
- 1999-07-15 EP EP99940783A patent/EP1096935A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
JP2002520361A (ja) | 2002-07-09 |
AU5456899A (en) | 2000-02-07 |
SE9802546D0 (sv) | 1998-07-15 |
EP1096935A1 (en) | 2001-05-09 |
WO2000003714A1 (en) | 2000-01-27 |
CA2336998A1 (en) | 2000-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9914696A (pt) | Composto, processo para tratamento de distúrbio mediado por ciclo-oxigenase-2 em um indivìduo, e, composição farmacêutica | |
BR0112224A (pt) | Composto, composição farmacêutica, uso de um composto ou de um sal, solvato ou pró-droga farmaceuticamente aceitável do mesmo, e, processo para preparar um composto | |
BR0114321A (pt) | Composto, composição farmacêutica, uso de um composto, método de tratamento ou profilaxia de doenças inflamatórias, e, processo para preparar um composto | |
TR200003478T2 (tr) | Antikanser maddeleri olarak faydalı izotiyazol türevleri | |
BG103945A (en) | Derivatives of 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a | |
IL171977A (en) | Cyclic sulfonamide for inhibition of gamma-secretase, process for its preparation and a pharmaceutical composition comprising the same | |
EA200100416A1 (ru) | 13-членные азалиды и их применение в качестве антибиотических агентов | |
HUT73433A (en) | Process for preparing pharmaceutical compositions containing riluzole for treating aids-related neural disorders | |
BG105543A (en) | Novel macrolide antibiotics | |
WO2005000863A3 (en) | 6, 11-4c-bicyclic 9a-azalide derivatives | |
CA2047744A1 (en) | Method for the synthesis of huperzine a and analogs thereof and compounds useful therein | |
DE69033369D1 (de) | 1,2,3,4-Tetrahydro-9-Akridinamine-Derivate | |
BR9814498A (pt) | Processo para o tratamento de obesidade em um humano necessitando de tal tratamento, composto, uso do mesmo, produto, e, composição farmacêutica | |
HUP0102903A2 (hu) | Nokatiacin antibiotikumok, eljárás az előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények | |
BR9912051A (pt) | Uso de composto, e, processo para tratamento e prevenção de discinesia. | |
WO1998021213A3 (en) | 2R,4S,R,S- and 2S,4R,R,S-hydroxyitraconazole- and hydroxysaperconazole derivatives | |
ATE310010T1 (de) | 6-0-substitutierte eryththromycin-verbindungen und verfahrenen zu ihrer herstellung | |
IL98970A0 (en) | Cyclopentane derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
BR0308837A (pt) | Composto, composição, método e medicamento para o tratamento de infecções bacterianas, psorìase ou artrite em mamìferos, método e medicamento para o tratamento de toxicidade devido a quimioterapia em um paciente, composição farmacêutica, processo para a preparação de um composto e processo para a conversão dos compostos da fórmula (i) em compostos adicionais da fórmula (i) | |
BR0006301A (pt) | Macrólidos antibacterianos e pró-cinéticos | |
BR0214606A (pt) | Processos para a preparação de derivados bicìclicos substituìdos para o tratamento de crescimento de célula anormal | |
BRPI0416284A (pt) | compostos, processo para a manufatura dos mesmos, composições farmacêuticas que os contêm, método para o tratamento e/ou prevenção de enfermidades que são moduladas por agonistas ppar(delta) e/ou ppar(alfa) e sua utilização | |
YU66900A (sh) | Derivati higromicina a | |
MX9707596A (es) | Benzamidas, el uso de las mismas, composiciones que las contienen, para el tratamiento del transtorno neurodegenerativo, y procedimiento para la preparacion del mismo. | |
BR9610175A (pt) | Composto processo de preparação do composto composição farmacêutica e utilização do composto |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application fees: dismissal - article 86 of industrial property law |
Free format text: REFERENTE A 5A E 12A ANUIDADES. |
|
B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 2135 DE 06/12/2011. |